Brief: Acurx Pharmaceuticals Reports Q3 2024 Results And Provides Business Update
13/11/2024 13:22
Nov 13 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* ACURX PHARMACEUTICALS, INC. REPORTS THIRD QUARTER 2024
RESULTS
AND PROVIDES BUSINESS UPDATE
* ACURX PHARMACEUTICALS INC: QTRLY LOSS PER SHARE $0.17
Source text: urn:newsml:reuters.com:*:nPn390Kj1a
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsAcurx Pharmaceuticals Q1 net loss narrows as expenses fall
Brief: Acurx Pharmaceuticals To Discuss First Quarter 2026 Financial Results On May 12, 2026 Conference Call And Provide Business Update
Brief: Acurx Pharmaceuticals, Inc. Announces Closing Of Up To $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Acurx Pharmaceuticals Q4 net loss narrows on lower R&D spend
Acurx Pharma Q3 net loss narrows to $2 mln